Literature DB >> 8164433

Alternative pathway activation of complement by cultured human proximal tubular epithelial cells.

L Biancone1, S David, V Della Pietra, G Montrucchio, V Cambi, G Camussi.   

Abstract

Human proximal tubular epithelial cells (PTEC) incubated with normal human serum (NHS) were found to fix on their surface C3, properdin, terminal complement components and C5b-9 MAC neoantigen, but not C1q and C4, by immunofluorescence. Complement fixation was abrogated if PTEC were incubated with EDTA-treated NHS or C3-deficient human serum, but not with Mg EGTA-treated NHS or C1q-deficient human serum, showing the prevalent activation of the alternative pathway of complement. This event was followed by marked cytoskeleton alterations with disruption of the actin cortical network, redistribution of actin throughout the cytoplasm and formation of blebs, and by cell cytolysis. In addition, superoxide anion and hydrogen peroxide production and chemiluminescence response were detected in consequence of MAC insertion on PTEC plasma membrane. The dependency on MAC of the observed biological effects of complement fixation on PTEC surface was shown by using sera selectively deficient of terminal components of complement (C6 or C8), and therefore unable to form the C5b-9 MAC, and by restoring the ability to form MAC after addition of purified C6 or C8. The possible pathogenetic relevance of these observations in tubulointerstitial injury occurring in patients with complementuria due to non-selective proteinuria, is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164433     DOI: 10.1038/ki.1994.59

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  40 in total

Review 1.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

Review 2.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

3.  Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis.

Authors:  A Nomura; Y Morita; S Maruyama; N Hotta; M Nadai; L Wang; T Hasegawa; S Matsuo
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

4.  Leaked protein and interstitial damage in the kidney: is complement the missing link?

Authors:  N S Sheerin; S H Sacks
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

Review 5.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

6.  Shift of C3 deposition from localization in the glomerulus into the tubulo-interstitial compartment in the absence of secreted IgM in immune complex glomerulonephritis.

Authors:  C Vaculik; B M Rüger; G Yanagida; D Hollemann; A Soleiman; U M Losert; J Chen; M B Fischer
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

7.  The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.

Authors:  Brandon Renner; Kathrin Coleman; Ryan Goldberg; Claudia Amura; Amanda Holland-Neidermyer; Kathryn Pierce; Heather N Orth; Hector Molina; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; V Michael Holers; Joshua M Thurman
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

8.  The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury.

Authors:  Constantino Fondevila; Xiu-Da Shen; Seiichiro Tsuchihashi; Yoichiro Uchida; Maria Cecilia Freitas; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2008-08       Impact factor: 5.799

Review 9.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

Review 10.  Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease.

Authors:  Paolo Cravedi; Giuseppe Remuzzi
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.